Nigella sativa and its protective role in oxidative stress and hypertension

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Leong, Xin Fang ^a,b   Rais Mustafa, Mohd ^c   Jaarin, Kamsiah ^a  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^c UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN I; ANTIHYPERTENSIVE AGENT; ASCORBIC ACID; ATROPINE; BLACK CUMIN EXTRACT; C REACTIVE PROTEIN; CATALASE; CYCLIC GMP; CYPROHEPTADINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED RELAXING FACTOR; GLUTATHIONE; GUANYLATE CYCLASE; HYDROCORTISONE; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MEPACRINE; OXIDIZED LOW DENSITY LIPOPROTEIN; PLANT EXTRACT; POLYUNSATURATED FATTY ACID; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THYMOL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VEGETABLE OIL; VERATRIC ACID;

ANTIHYPERTENSIVE ACTIVITY; ANTIOXIDANT ACTIVITY; BLACK CUMIN; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; DIURESIS; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; HEART PROTECTION; HUMAN; HYPERTENSION; IC 50; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SMOOTH MUSCLE RELAXATION; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; VASCULAR SMOOTH MUSCLE;

EID: 84875456204     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/120732     Document Type: Review

References (77)

1. Chobanian A. V., Bakris G. L., Black H. R., Cushman W. C., Green L. A., Izzo J. L. Jr., Jones D. W., Materson B. J., Oparil S., Wright J. T. Jr., Roccella E. J., The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. The Journal of the American Medical Association 2003 289 19 2560 2572 2-s2.0-0038460302 10.1001/jama.289.19.2560 (Pubitemid 37430158)
2. Khor G. L., Cardiovascular epidemiology in the Asia-Pacific region. Asia Pacific Journal of Clinical Nutrition 2001 10 2 76 80 2-s2.0-0035236938 (Pubitemid 33739333)
3. Vorster H. H., The emergence of cardiovascular disease during urbanisation of Africans. Public Health Nutrition 2002 5 1A 239 243 2-s2.0-0036463833 10.1079/PHN2001299 (Pubitemid 41128313)
4. Mellen P. B., Gao S. K., Vitolins M. Z., Goff D. C. Jr., Deteriorating dietary habits among adults with hypertension: dash dietary accordance, NHANES 1988-1994 and 1999-2004. Archives of Internal Medicine 2008 168 3 308 314 2-s2.0-39549091283 10.1001/archinternmed.2007.119 (Pubitemid 351281678)
5. Schuur M., van Switen J. C., Schol-Gelok S., Genetic risk factors for cerebral small-vessel disease in hypertensive patients from a genetically isolated population. Journal of Neurology, Neurosurgery and Psychiatry 2011 82 1 41 44 2-s2.0-78650505190 10.1136/jnnp.2009.176362
6. Shook R. P., Lee D., Sui X., Cardiorespiratory fitness reduces the risk of incident hypertension associated with a parental history of hypertension. Hypertension 2012 59 6 1220 1224 10.1161/HYPERTENSIONAHA.112.191676
7. Institute for Public Health, The Third National Health and Morbidity Survey (NHMS III) 2006 2008 Putrajaya, Malaysia Ministry of Health
8. Kearney P. M., Whelton M., Reynolds K., Muntner P., Whelton P. K., He J., Global burden of hypertension: analysis of worldwide data. The Lancet 2005 365 9455 217 223 2-s2.0-12344282783 10.1016/S0140-6736(05)17741-1 (Pubitemid 40138015)
9. Meddah B., Ducroc R., El Abbes-Faouzi M., Eto B., Mahraoui L., Benhaddou-Andaloussi A., Martineau L. C., Cherrah Y., Haddad P. S., Nigella sativa inhibits intestinal glucose absorption and improves glucose tolerance in rats. Journal of Ethnopharmacology 2009 121 3 419 424 2-s2.0-58149215637 10.1016/j.jep.2008.10.040
10. Nagi M. N., Almakki H. A., Thymoquinone supplementation induces quinone reductase and glutathione transferase in mice liver: possible role in protection against chemical carcinogenesis and toxicity. Phytotherapy Research 2009 23 9 1295 1298 2-s2.0-69749091547 10.1002/ptr.2766
11. Kocyigit Y., Atamer Y., Uysal E., The effect of dietary supplementation of Nigella sativa L. on serum lipid profile in rats. Saudi Medical Journal 2009 30 7 893 896 2-s2.0-70349503806
12. Taşar N., Şehirli O., Yiǧner O., Protective effects of Nigella sativa against hypertension-induced oxidative stress and cardiovascular dysfunction in rats. Marmara Pharmaceutical Journal 2012 16 2 141 149
13. Ghannadi A., Hajhashemi V., Jafarabadi H., An investigation of the analgesic and anti-inflammatory effects of Nigella sativa seed polyphenols. Journal of Medicinal Food 2005 8 4 488 493 2-s2.0-31044439509 10.1089/jmf.2005.8.488 (Pubitemid 43121901)
14. Terzi A., Coban S., Yildiz F., Ates M., Bitiren M., Taskin A., Aksoy N., Protective effects of Nigella sativa on intestinal ischemia-reperfusion injury in rats. Journal of Investigative Surgery 2010 23 1 21 27 2-s2.0-77949543599 10.3109/08941930903469375
15. El-Tahir K. E. H., Ashour M. M., AlHarbi M. M., The cardiovascular actions of the volatile oil of the black seed (Nigella sativa) in rats: elucidation of the mechanism of action. General Pharmacology 1993 24 5 1123 1131 2-s2.0-0027264732 (Pubitemid 23283080)
16. El-Tahir K. E. H., Ageel A. M., Effect of volatile oil of Nigella sativa on the arterial blood pressure and heart rate of the guinea-pig. Saudi Pharmaceutical Journal 1994 2 4 163 168
17. El-Tahir K. E. H., Al-Ajmi M. F., Al-Bekairi A. M., Some cardiovascular effects of the dethymoquinonated Nigella sativa volatile oil and its major components α -pinene and p-cymene in rats. Saudi Pharmaceutical Journal 2003 11 3 104 110 2-s2.0-0043131868 (Pubitemid 36944244)
18. Peixoto-Neves D., Silva-Alves K. S., Gomes M. D., Vasorelaxant effects of the monoterpenic phenol isomers, carvacrol and thymol, on rat isolated aorta. Fundamental and Clinical Pharmacology 2010 24 3 341 350 2-s2.0-77952566778 10.1111/j.1472-8206.2009.00768.x
19. Szentandrássy N., Szigeti G., Szegedi C., Sárközi S., Magyar J., Bányász T., Csernoch L., Kovács L., Nánási P. P., Jóna I., Effect of thymol on calcium handling in mammalian ventricular myocardium. Life Sciences 2004 74 7 909 921 2-s2.0-10744231293 10.1016/j.lfs.2003.09.034 (Pubitemid 37501139)
20. Zaoui A., Cherrah Y., Lacaille-Dubois M. A., Settaf A., Amarouch H., Hassar M., Diuretic and hypotensive effects of Nigella sativa on the spontaneously hypertensive rat. Therapie 2000 55 3 379 382 2-s2.0-0034186616 (Pubitemid 30481173)
21. Zeggwagh N. A., Moufid A., Khaldi A., Michel J. B., Eddouks M., Singh V. K., Govil J. N., Cardiovascular effect of Nigella sativa aqueous extract in spontaneously hypertensive rats. Chemistry and Medicinal Value 2009 Houston, Tex, USA Studium Press 243 252
22. Khattab M. M., Nagi M. N., Thymoquinone supplementation attenuates hypertension and renal damage in nitric oxide deficient hypertensive rats. Phytotherapy Research 2007 21 5 410 414 2-s2.0-34248165186 10.1002/ptr.2083 (Pubitemid 46715078)
23. Sayed H. M., El-Latif H. A. A., Eid N. I., Elsayed A. Z., El-Kader E. M. A., Potential antihypertensive and antioxidative effects of Nigella sativa seeds or biomass and Syzygium aromaticum extracts on L-NAME-induced hypertensive rats. Egyptian Journal of Pharmaceutical Sciences 2009 50 127 146
24. Dehkordi F. R., Kamkhah A. F., Antihypertensive effect of Nigella sativa seed extract in patients with mild hypertension. Fundamental and Clinical Pharmacology 2008 22 4 447 452 2-s2.0-55949121968 10.1111/j.1472-8206.2008. 00607.x
25. Meziti A., Meziti H., Boudiaf K., Mustapha B., Bouriche H., Polyphenolic profile and antioxidant activities of Nigella sativa seed extracts in vitro and in vivo. World Academy of Science, Engineering and Technology 2012 64 6 24 32
26. Al-Naqeeb G., Ismail M., Al-Zubairi A. S., Fatty acid profile, α -tocopherol content and total antioxidant activity of oil extracted from Nigella sativa seeds. International Journal of Pharmacology 2009 5 4 244 250 2-s2.0-70449370991 10.3923/ijp.2009.244.250
27. Ali, Blunden G., Pharmacological and toxicological properties of Nigella sativa. Phytotherapy Research 2003 17 4 299 305 2-s2.0-0038559976 10.1002/ptr.1309 (Pubitemid 36565330)
28. Nergiz C., Otles S., Chemical composition of Nigella sativa L. seeds. Food Chemistry 1993 48 3 259 261 2-s2.0-0027323712 10.1016/0308-8146(93)90137-5 (Pubitemid 23249459)
29. Ghosheh O. A., Houdi A. A., Crooks P. A., High performance liquid chromatographic analysis of the pharmacologically active quinones and related compounds in the oil of the black seed (Nigella sativa L.). Journal of Pharmaceutical and Biomedical Analysis 1999 19 5 757 762 2-s2.0-0033120349 10.1016/S0731-7085(98)00300-8 (Pubitemid 29092778)
30. Badary O. A., Taha R. A., Gamal El-Din A. M., Abdel-Wahab M. H., Thymoquinone is a potent superoxide anion scavenger. Drug and Chemical Toxicology 2003 26 2 87 98 2-s2.0-0037570817 10.1081/DCT-120020404 (Pubitemid 36597385)
31. Nagi M. N., Alam K., Badary O. A., Al-Shabanah O. A., Al-Sawaf H. A., Al-Bekairi A. M., Thymoquinone protects against carbon tetrachloride hepatotoxicity in mice via an antioxidant mechanism. Biochemistry and Molecular Biology International 1999 47 1 153 159 2-s2.0-0033065662 (Pubitemid 29112715)
32. Badary O. A., Nagi M. N., Al-Shabanah O. A., Al-Sawaf H. A., Al-Sohaibani M. O., Al-Bekairi A. M., Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity. Canadian Journal of Physiology and Pharmacology 1997 75 12 1356 1361 2-s2.0-0031431309 10.1139/cjpp-75-12-1356 (Pubitemid 28130377)
33. Al-Shabanah O. A., Badary O. A., Nagi M. N., Al-Garably N. M., Al-Rikabi A. C., Al-Bekairi A. M., Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity. Journal of Experimental and Clinical Cancer Research 1998 17 2 193 198 2-s2.0-0031841827 (Pubitemid 28335578)
34. Kruk I., Michalska T., Lichszteld K., Kladna A., Aboul-Enein H. Y., The effect of thymol and its derivatives on reactions generating reactive oxygen species. Chemosphere 2000 41 7 1059 1064 2-s2.0-0034120730 10.1016/S0045- 6535(99)00454-3 (Pubitemid 30390037)
35. Mansour M. A., Nagi M. N., El-Khatib A. S., Al-Bekairi A. M., Effects of thymoquinone on antioxidant enzyme activities, lipid peroxidation and dt-diaphorase in different tissues of mice: a possible mechanism of action. Cell Biochemistry and Function 2002 20 2 143 151 2-s2.0-0036090986 10.1002/cbf.968 (Pubitemid 34517369)
36. Nagi M. N., Mansour M. A., Protective effect of thymoquinone against doxorubicin-induced cardiotoxicity in rats: a possible mechanism of protection. Pharmacological Research 2000 41 3 283 289 2-s2.0-0033836675 10.1006/phrs.1999.0585 (Pubitemid 30663132)
37. Ismail M., Al-Naqeep G., Chan K. W., Nigella sativa thymoquinone-rich fraction greatly improves plasma antioxidant capacity and expression of antioxidant genes in hypercholesterolemic rats. Free Radical Biology and Medicine 2010 48 5 664 672 2-s2.0-75149187342 10.1016/j.freeradbiomed.2009.12. 002
38. Erşahin M., Toklu H. Z., Akakin D., Yuksel M., Yeǧen B. C., Sener G., The effects of Nigella sativa against oxidative injury in a rat model of subarachnoid hemorrhage. Acta Neurochirurgica 2011 153 2 333 341 10.1007/s00701-010-0853-9
39. Sheikh B. Y., Mohamadin A. M., Thymoquinone a potential therapy for cerebral oxidative stress. Asian Journal of Natural and Applied Sciences 2012 1 2 76 92
40. Sayed-Ahmed M. M., Nagi M. N., Thymoquinone supplementation prevents the development of gentamicin-induced acute renal toxicity in rats. Clinical and Experimental Pharmacology and Physiology 2007 34 5-6 399 405 2-s2.0-33947638565 10.1111/j.1440-1681.2007.04560.x (Pubitemid 46494460)
41. Urso M. L., Clarkson P. M., Oxidative stress, exercise, and antioxidant supplementation. Toxicology 2003 189 1-2 41 54 2-s2.0-0038342017 10.1016/S0300-483X(03)00151-3 (Pubitemid 36733566)
42. Grotto D., Santa Maria L., Valentini J., Paniz C., Schmitt G., Garcia S. C., Pomblum V. J., Rocha J. B. T., Farina M., Importance of the lipid peroxidation biomarkers and methodological aspects for malondialdehyde quantification. Quimica Nova 2009 32 1 169 174 2-s2.0-62749141950 10.1590/S0100-40422009000100032
43. Ceretta L. B., Réus G. Z., Abelaira H. M., Increased oxidative stress and imbalance in antioxidant enzymes in the brains of alloxan-induced diabetic rats. Experimental Diabetes Research 2012 2012 8 302682 10.1155/2012/302682
44. Raut A. M., Suryakar A. N., Mhaisekar D., Study of oxidative stress in relation with antioxidant status in chronic bronchitis. International Journal of Medicine and Medical Sciences 2012 4 2 75 77
45. Armas-Padilla M. C., Armas-Hernández M. J., Sosa-Canache B., Cammarata R., Pacheco B., Guerrero J., Carvajal A. R., Hernández- Hernández R., Israili Z. H., Valasco M., Nitric oxide and malondialdehyde in human hypertension. The American Journal of Therapeutics 2007 14 2 172 176 2-s2.0-34247165093 10.1097/01.pap.0000249914.75895.48 (Pubitemid 46597656)
46. Meera K. S., Oxidative imbalance in smokers with and without hypertension. Biomedical Research 2011 22 3 267 272 2-s2.0-79960802314
47. Verma S., Anderson T. J., Fundamentals of endothelial function for the clinical cardiologist. Circulation 2002 105 5 546 549 2-s2.0-0037022256 10.1161/hc0502.104540 (Pubitemid 34123425)
48. Nishizaka M. K., Zaman M. A., Green S. A., Renfroe K. Y., Calhoun D. A., Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism. Circulation 2004 109 23 2857 2861 2-s2.0-2942685646 10.1161/01.CIR.0000129307.26791.8E (Pubitemid 38780298)
49. Leong X.-F., Mustafa M. R., Das S., Jaarin K., Association of elevated blood pressure and impaired vasorelaxation in experimental Sprague-Dawley rats fed with heated vegetable oil. Lipids in Health and Disease 2010 9 article 66 2-s2.0-77953714924 10.1186/1476-511X-9-66
50. Peluffo G., Calcerrada P., Piacenza L., Pizzano N., Radi R., Superoxide-mediated inactivation of nitric oxide and peroxynitrite formation by tobacco smoke in vascular endothelium: studies in cultured cells and smokers. The American Journal of Physiology 2009 296 6 H1781 H1792 2-s2.0-66949153972 10.1152/ajpheart.00930.2008
51. Dzau V. J., Tissue angiotensin and pathobiology of vascular disease a unifying hypothesis. Hypertension 2001 37 4 1047 1052 2-s2.0-0035048905 (Pubitemid 32304002)
52. Wing L. M. H., Reid C. M., Ryan P., Beilin L. J., Brown M. A., Jennings G. L. R., Johnston C. I., McNeil J. J., Macdonald G. J., Marley J. E., Morgan T. O., West M. J., A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. The New England Journal of Medicine 2003 348 7 583 592 2-s2.0-0037434556 10.1056/NEJMoa021716 (Pubitemid 36204952)
53. van Vark L. C., Bertrand M., Akkerhuis K. M., Brugts J. J., Fox K., Mourad J. J., Boersma E., Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients. European Heart Journal 2012 33 16 2088 2097 10.1093/eurheartj/ehs075
54. Rajagopalan S., Kurz S., Münzel T., Tarpey M., Freeman B. A., Griendling K. K., Harrison D. G., Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. Journal of Clinical Investigation 1996 97 8 1916 1923 2-s2.0-0030005713
55. Kdziora-Kornatowska K. Z., Luciak M., Paszkowski J., Lipid peroxidation and activities of antioxidant enzymes in the diabetic kidney: effect of treatment with angiotensin convertase inhibitors. IUBMB Life 2000 49 4 303 307 2-s2.0-0343090457 (Pubitemid 30421857)
56. Cowling R. T., Zhang X., Reese V. C., Iwata M., Gurantz D., Dillmann W. H., Greenberg B. H., Effects of cytokine treatment on angiotensin II type 1A receptor transcription and splicing in rat cardiac fibroblasts. The American Journal of Physiology 2005 289 3 H1176 H1183 2-s2.0-23944509715 10.1152/ajpheart.00088.2005 (Pubitemid 41208961)
57. Ruiz-Ortega M., Ruperez M., Lorenzo O., Esteban V., Blanco J., Mezzano S., Egido J., Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney International, Supplement 2002 62 82 S12 S22 2-s2.0-0036433105 (Pubitemid 35356990)
58. Elmarakby A. A., Imig J. D., Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive rats. Clinical Science 2010 118 4 291 301 2-s2.0-70549099724 10.1042/CS20090395
59. Mehta J. L., Li D., Facilitative interaction between angiotensin II and oxidised LDL in cultured human coronary artery endothelial cells. Journal of the Renin-Angiotensin-Aldosterone System 2001 2 1, supplement S70 S76 2-s2.0-0001916723
60. Li D., Saldeen T., Romeo F., Mehta J. L., Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF- B. Circulation 2000 102 16 1970 1976 2-s2.0-0034680307
61. Rodrigo R., Passalacqua W., Araya J., Orellana M., Rivera G., Implications of oxidative stress and homocysteine in the pathophysiology of essential hypertension. Journal of Cardiovascular Pharmacology 2003 42 4 453 461 2-s2.0-0141865506 10.1097/00005344-200310000-00001 (Pubitemid 37210858)
62. Miyajima K., Minatoguchi S., Ito Y., Hukunishi M., Matsuno Y., Kakami M., Kawasaki M., Nishigaki K., Takemura G., Fujiwara H., Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension. Hypertension Research 2007 30 4 307 313 2-s2.0-34249080316 10.1291/hypres.30.307 (Pubitemid 46779979)
63. Guzik T. J., West N. E. J., Pillai R., Taggart D. P., Channon K. M., Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels. Hypertension 2002 39 6 1088 1094 2-s2.0-0036285223 10.1161/01.HYP.0000018041.48432.B5 (Pubitemid 34620129)
64. Cracowski J. L., Degano B., Chabot F., Independent association of urinary F2-isoprostanes with survival in pulmonary arterial hypertension. Chest 2012 142 4 869 876
65. Landmesser U., Dikalov S., Price S. R., McCann L., Fukai T., Holland S. M., Mitch W. E., Harrison D. G., Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. Journal of Clinical Investigation 2003 111 8 1201 1209 2-s2.0-0037399439 10.1172/JCI200314172 (Pubitemid 36519937)
66. Zalba G., José G. S., Moreno M. U., Fortuño M. A., Fortuño A., Beaumont F. J., Díez J., Oxidative stress in arterial hypertension role of NAD(P)H oxidase. Hypertension 2001 38 6 1395 1399 2-s2.0-0035678477 (Pubitemid 34033422)
67. Chen X., Touyz R. M., Park J. B., Schiffrin E. L., Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 2001 38 3 606 611 2-s2.0-0035460097
68. Schiffrin E. L., Beyond blood pressure: the endothelium and atherosclerosis progression. The American Journal of Hypertension 2002 15 10 115S 122S 2-s2.0-0036794272 (Pubitemid 35155530)
69. McIntyre M., Bohr D. F., Dominiczak A. F., Endothelial function in hypertension: the role of superoxide anion. Hypertension 1999 34 4 I 539 545 2-s2.0-0032699683 (Pubitemid 29496430)
70. Amanullah M., Zaman G. S., Rahman J., Rahman S. S., Lipid peroxidation and the levels of antioxidant enzymes in hypertension. Free Radicals and Antioxidants 2012 2 2 12 18 10.5530/ax.2012.2.2.3
71. Rodrigo R., Prat H., Passalacqua W., Araya J., Guichard C., Bächler J. P., Relationship between oxidative stress and essential hypertension. Hypertension Research 2007 30 12 1159 1167 2-s2.0-38749104742 10.1291/hypres.30.1159 (Pubitemid 351176413)
72. Nwanjo H. U., Oze G., Okafor M. C., Nwosu D., Nwankpa P., Oxidative stress and non-enzymatic antioxidant status in hypertensive patients in Nigeria. African Journal of Biotechnology 2007 6 14 1681 1684 (Pubitemid 47195805)
73. Saravanakumar M., Raja B., Veratric acid, a phenolic acid attenuates blood pressure and oxidative stress in L-NAME induced hypertensive rats. European Journal of Pharmacology 2011 671 1-3 87 94 2-s2.0-80455122700 10.1016/j.ejphar.2011.08.052
74. Park E., Shin J. I., Park O. J., Kang M. H., Soy isoflavone supplementation alleviates oxidative stress and improves systolic blood pressure in male spontaneously hypertensive rats. Journal of Nutritional Science and Vitaminology 2005 51 4 254 259 2-s2.0-25144457051 (Pubitemid 41355261)
75. Bogdanski P., Suliburska J., Szulinska M., Stepien M., Pupek-Musialik D., Jablecka A., Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients. Nutritional Research 2012 32 6 421 427 10.1016/j.nutres.2012.05.007
76. Rodrigo R., Prat H., Passalacqua W., Araya J., Bächler J. P., Decrease in oxidative stress through supplementation of vitamins C and E is associated with a reduction in blood pressure in patients with essential hypertension. Clinical Science 2008 114 9-10 625 634 2-s2.0-42649141621 10.1042/CS20070343 (Pubitemid 351596387)
77. Magyar J., Szentandrássy N., Bányász T., Fülöp L., Varró A., Nánási P. P., Effects of terpenoid phenol derivatives on calcium current in canine and human ventricular cardiomyocytes. European Journal of Pharmacology 2004 487 1-3 29 36 10.1016/j.ejphar.2004.01.011 (Pubitemid 38368979)